Antihyperlipidemics Flashcards

1
Q

Hypercholesterolemia
HyperTG
Mixed

A
Inc cholesterol (normally LDL)
Inc TG (usually VLDL)
Inc serum TG and cholesterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Altering VLDL, LDL, and HDL

A

VLDL - modestly promotes AS…promotes acute pancreatitis
LDL - promotes athero
HDL - prtective against AS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HMG-CoA reductase inhibitors

A

Statins

LActone containing statins are prodrugs that must be hydrolyxed

Statins have very strong effect on total cholesterol and LDL and moderate for TGs and VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Statins -use

A

Best for treating hypercholesterolemia and preventing CV events in pts with coronary heart dz

ALso used to tx MOD hypertriglyceridemia and mixed hyperlipidemia

Other drugs dec VLDL more but statins dec CV risk most

Other drugs preferred if severe and immediate tx needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Statin MOA

A

Act on hepatocytes ot block HMG-CoA reductase…rate limiting step in cholesterol biosyntehsis

Biggest drop in LDL comes from inc hepatic uptake…hepatocyte compensate for dec cholesterol synthesis by inc LDL receptor expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pleiotropic effects of statins

A

Improved endothelial function - inc vasodilation

Anti-inflam…slow plaque progression and stabilizes established plauqes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Statin adverse and contraindication

A

Skeletal muscle toxoicty
Hepatoxicity - asx and modest inc in serum transminases
T2DM - inc in incidnece

Contra in preg or nursing due to skeletal defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Muscle toxicity mech and risk factors for statins

A

Releases K+ (causing arrhythmias) and myoglobin (renal damage)

Higher statin dosease, co-admin of CYP450s, inhibitors of hepatic drug transporters

East asian descenet or OATP1B1 genotypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Summary of
Atorvastitin
Rosuvastatin
Pravastatin

PKs and interactions

A

Mod sensitivie to CYP3A4 inhibs

Sens to inhibis of biliary drug transporter

Statin least affected by drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PCSK9 inhibitors

A

Evolocumab

Self adm subq injection every 2 week or month

Only used for very high risk hypercholesterolemia pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PCSK9 fxn

A

Secreted into blood by hepatocytes, binds to LDL receptors

LDL-R bound with PCSK9 internalized

If PCSK9 is bound, LDL receptor destroyed rather than recylced

Fewer LDL receptors dec hepatocyte uptake of LDL cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Effects of PCSK9 inhibs

A

Dec destruction of LDL receptors

mroe LDL receptors on hepatic membranes

inc uptake of LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

PCSK9 PJs

A

Slow, prolonged absorption

Slowly cleared by liver

Extensively bound to plasma proteins to extend duration of action

Rapidly acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Evolocumab adverse effects

and guielines

A

Injection site rxns

Nasopharyngitis/influenza due to immune suppression

Guidelines - heterozygous famialhypercholesterolemia or established AS dz…supposed to added to dietary changes nad max statin theapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Selective cholesterol uptake inhibitor

A

Ezetimibe

Binds and ingibits NPC1L1 in the gut

Dec cholesterol absoprtion also induced upregulation of heptaic LDL receptors and hepatic LDL uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ezetimibe use

A

ALone for hypercholesterolemia who can’t take statins

Single pill combos with statins available - for secondary prevention

17
Q

Bile acid sequestrants

A

Unabsorbable positively charged resins

Fewer adverse efects

Avoid when significant hypertriglyceridemia present

18
Q

MOA of bile acid sequestration

A

Dec enterohepatic recirculation of bile acid

Stimulates use of hepatic cholesterol to synthesize replacement bile acids

inc LDL receptor expression to scavenage more LDL cholesterol from blood

19
Q

Use of sequestrants and adverse effects

A

Hypercholesterolemia add on therapy

T2DM add on - dec LDL and CV risk…also reduces glycosylated Hb in T2DM

GI issues and dec absorptiojn of neg charged things

20
Q

Fibrates

A

Hepatic elim

Dec VLDL

Can inc LDL in hypertriglyceridemia pts bc converts VLDL to LDL

21
Q

Fenofibrate use

A

Hypertriglyceridemia

Mod - long term reudciton of risk from AS CV d…statins are highly recommended

Severe- reduction of acute pancreatitis risk, fibrates highly recommened.

22
Q

Fibrate MOA

A

Perixosome proliferator-activated receptor alpha agonist

PPAR-alpha is a nuclear receptor that regulates protein expression in liver and muscle

Activated PPAR-alpha trnalsocates into hucleus and heterodimerizes with reitnoid X receptor before binding t DNA and altering gene transcripton

23
Q

Fibrate VLDL effects

A

Either dec VLDL synthesis or increase metabolism

24
Q

Fibrates adverse effects and in diabetes

A

Cholelithias, hepatotoxcity

T2DM - dec non-fatal CV events, dec neprhopathy and retinopathy

25
Q

Niacin

A

Inc HDL and dec VLDL

Dec VLDL in liver by dec triglyceride synthesi

Second line drug for add on of hypertriglyceridemia…best drug to tx low HDL

26
Q

Niacin AE

A

GI irritation
Cutaenous flushing - PG induced vsodilation (take aspirin)
Dec insulin sensitivity
Hepatocotiy

27
Q

Forms of niacin and AE

A

Immediate release - flushing

Sustained release (Supplement) - hepatotoxic

Prescription ER - less flushing than immediate